Cyclospora Diagnostic Testing Market

Global Cyclospora Diagnostic Testing Market: Overview

Cyclospora is a one celled organism commonly found in temperate climates that causes gastrointestinal disorders in humans. Cyclosporiasis is an affliction that affects millions of people worldwide and is spread via contaminated food and water.

Global hygiene standards and water supply are dwindling by the day. As populations rise amid a severe fresh water paucity, demands for potable water have never been higher. This increases the incidence of water borne diseases and cyclospora diagnostic testing market would grow at a sturdy CAGR over the forecast period of 2020 to 2030, claims Transparency Market Research.

Global Cyclospora Diagnostic Testing Market: Competitive Landscape

A number of manufacturers are responsible for the production of cyclosporiasis diagnostic kits. This makes the market scenario fragmented. Major players include-

• Thermo Fisher Scientific
• Beckman Coulter, Inc
• bioMerieux, Inc.
• CEPHEID
• Diamedix Corporation
• Hologic, Inc
• Nanogen, Inc.
• Ortho Clinical Diagnostics (a Johnson & Johnson company)
• DiaSorin S.p.A., Roche Diagnostics (a division of Hoffmann-La Roche)
• Siemens Healthcare
• QIAGEN N.V.
• Wako Chemicals USA, Inc.

These manufacturers recognize coming trends in this market and are ready to increase supply to cater to fresh demand. This can be done by funding innovations in the cyclospora diagnostic testing market and acquiring facilities that manufacture subparts of a diagnostic test.

Global Cyclospora Diagnostic Testing Market: Key Trends and Drivers

• Water demand globally is projected to increase by 55% between 2000 and 2050. Most is driven by agriculture, which accounts for 70% of global freshwater use. As global population is expected to touch 11 billion by 2100, water paucity should lead people to recycle and take in unclean water.
• The healthcare sector is expanding to cater to global demands. Diagnostic testing, including that for cyclospora should see a concomitant rise in the coming years. This will help the market chat notable growth trajectory over the forecast period stated above.

Global Cyclospora Diagnostic Testing Market: Regional Analysis

North America and Europe are currently global leaders in the cyclospora diagnostic testing market owing to the presence of a robust healthcare infrastructure that supports innovations.

The Asia Pacific region (APAC) is expected to register the fastest growth in this market given the rising paucity for non potable water. As acceptance for modern diagnosis increases in this region, so should the market for cyclospora diagnosis.